Industry focus: Healthcare and life sciences

Gaëlle MERLIER

Gaëlle MERLIER is co-head of the Life Sciences Department. Gaëlle’s expertise spans advisory work on regulatory and contractual matters as well as the management of complex, serial litigation in commercial matters and health product liability. She also assists her clients during criminal investigations and in their dealings with the health authorities (particularly in the context of ANSM, DGCCRF, DDPP inspections, etc.). Furthermore, Gaëlle advises her clients on mergers-acquisitions and investments in the health sector (pharmaceutical companies, medical device manufacturers, clinical laboratories and other regulated health professions). Finally, she contributes to the launch of compliance programmes (anti-gift legislation, Sapin 2 Act, lobbying, etc.).

Sophie Pelé

Partner

Anne-Charlotte Rivière

Partner

Eveline Van Keymeulen

Eveline Van Keymeulen is a partner in Latham & Watkins' Brussels and Paris offices and Global Vice Chair of Latham & Watkins' Healthcare & Life Sciences Practice. She advises multinational companies and start-ups in the pharmaceutical, biotech, medical devices, cosmetics, and food and beverage sectors on a broad variety of complex European, domestic and cross-border regulatory matters, including clinical trials, product approvals, regulatory incentives, market access, promotion and advertising, post-market obligations, and general compliance matters. In addition, Eveline has extensive experience advising on cannabis and hemp-based product regulations. She successfully challenged the legality of French hemp regulations in the first landmark case related to cannabidiol (CBD) products before the Court of Justice of the European Union (Case C-663/18, Kanavape). This transaction won the Creating New Standards award at the Financial Times European Innovative Lawyer Awards 2022. Eveline has authored numerous articles and has been a featured speaker on EU regulatory matters at prominent conferences such as the Pharmaceutical Law Academy in Cambridge. She also serves on the editorial board of the European Pharmaceutical Law Review. In addition, Eveline has been quoted in BBC Business Daily, Bloomberg, The Times, Les Echos, and other leading international business journals on life sciences regulatory and policy matters.

Armand Aviges

Partner

Thomas Baudesson

Thomas Baudesson specialises in commercial litigation and more particularly commercial contracts, corporate, product liability, labour law, domestic arbitration, white collar crimes, injunctions and conservatory measures. Thomas regularly advises on matters related to industrials, particularly aerospace & defence and automotive.

Gilles Bigot

Partner - Corporate / Healthcare

Charlotte Damiano

Partner

Alain Decombe

Partner

Raphaëlle Dequiré-Portier

Raphaëlle Dequiré-Portier is a partner in Gide Loyrette Nouel's Intellectual Property, Telecoms, Media & Technology Department. Her practice focuses mainly on advising and assisting clients in disputes with regard to patents and trademark law. She has gained wide experience in domestic and pan-European disputes, particularly in the field of patent infringements and the validity of patents. Raphaëlle also advises on copyright issues and unfair competition law. Raphaëlle Dequiré-Portier defends and advises some of the world's leading brands, notably in the luxury, jeanswear and consumer goods sectors. In patent law matters, she has advised on the most recent cases concerning drugs, particularly with regard to supplementary protection certificates.

Jean-Marie Job

Firm partner, Jean-Marie Job has developed highly specialised expertise in various areas of health and especially in the fields of pharmaceuticals and biotechnology. He is also involved in the creation of IT contracts and issues related to the management of personal and commercial data. He represents numerous clients before the CNIL (Commission Nationale de l'Informatique et des Libertés). Before joining the law firm of de Gaulle Fleurance & Associés in 2001, he practiced for fifteen years in the legal department of Aventis. Jean-Marie Job is an honorary member of the Association of Pharmaceutical Industry Counsels and regularly lecturers on health law. He is also recognised by the CNIL as a recommended interlocutor. He lecturers in "data-privacy of personal health data" and "rules and laws governing clinical testing" at Paris-VI University. Jean-Marie Job was nominated by his peers “Lawyer of the Year 2011 in Biotechnology” by the Best Lawyers Awards (In partnership with Les Echos).

Anthony Paronneau

Anthony Paronneau is a partner, he advises clients on all aspects of corporate and business law, with a particular focus on pharmaceutical, medical device, biotech and health care industries. Anthony has significant experience advising life sciences companies, private equity funds and venture capital firms on a number of merger and acquisition (M&A) and private equity transactions, including acquisitions, financing rounds, joint ventures and divestitures. He also regularly advises life sciences companies on collaborations, licensing and distribution arrangements. For further details of Anthony's biography, please view McDermott website here.

François Pochart

Partner

Emmanuelle Porte

Emmanuelle is co-managing partner of Bird & Bird France.Emmanuelle advises companies and venture capital funds on fund-raising processes, M&A transactions, private placements and IPOs.She specialises in venture capital, M&A and corporate finance transactions within the Life Sciences & Healthcare sector. She focuses in particular on clients in the biotech, medtech and healthcare industries, although she also works for clients in the Tech & Comms sector. Emmanuelle's practice frequently involves advising small to mid-size corporate clients on fundraising processes, both within the French market and overseas. Her expertise includes advising start-ups and those selling new technologies on M&A, private placements and IPOs as well as general corporate and commercial matters.

Mikael Salmela

Partner

Cécile Théard-Jallu

Firm partner, Cécile Théard-Jallu has developed in-depth expertise as an attorney in private practice representing multinational corporations, including major US and European firms and organizations in the R&D and healthcare sector (public or private research institutions, academics, pharmaceutical laboratories, biotechnology companies, medical equipment manufacturers, service providers, software or connected health platforms publishers, investors, competitiveness clusters, tech transfer agencies and other intermediaries in the field of innovation…) as well as in other industrial sectors such as energy or transportation, but also in the field of IT and services. Cecile focuses primarily on complex transactions including R&D and consortiums, technology transfers, licensing deals and other technological change related projects. She assists clients with their responses to calls for projects in the R&D and innovation sector in the context of public funding, for instance, with respect to the future investments program (Programme des Investissements d’Avenir) conducted by the French Government.She also advises them on the structuring of their contractual flows as well as the design, drafting, negotiation and enforcement of their commercial or IT contracts. She assists clients on the building and implementation of their digital health strategy.Cécile is ranked among the Best Lawyers in France in Biotechnology and Information Technology law (ranking published by the US publisher Best Lawyers in cooperation with the French newspaper Les Echos).

Mélanie Thill-Tayara

Partner

Emmanuelle Trombe

Partner Emmanuelle Trombe represents pharmaceutical, medical device and bio-pharmaceutical companies globally in transactional matters in relation to M&A and divestitures, joint ventures and strategic partnerings, large-scale projects, outsourcing projects, product development, licensing agreements and regulatory matters. She also advises venture capital funds and bio-pharmaceutical companies in connection with a broad range of financing activities. For further details of Emmanuelle's biography, please view McDermott website here.

Ombline Ancelin

Partner

Jean-Marc Grosperrin

Jean-Marc Grosperrin, a Partner in Dentons’ Paris office, is primarily involved in French and cross-border acquisitions, private equity transactions and industrial M&A transactions. Jean-Marc regularly advises major international groups as well as mid-sized companies in a variety of sectors. Besides advising French and foreign companies on their acquisitions or divestitures in France and abroad, he also represents investment funds and managers in leveraged transactions. Jean-Marc is Global Chair of Dentons’ Life Science & Healthcare group and Co-head of the Europe and Paris Life Sciences groups. He also serves as a member of Dentons Europe Board.

Pascale Poupelin

Pascale Poupelin, Senior Counsel at Dentons' Paris Office, is recognized for her excellent skills in Life Sciences and Healthcare, but also praised by clients for being very pragmatic and collaborative. She focuses on judicial and administrative litigation, contractual and regulatory issues as well as market access, pricing, reimbursement, data protection, e-Health compliance, clinical trials, advertising, structuring of operational companies, manufacturing, distribution, marketing and licensing, public’s health product tenders, defective products and recall. With more than 30 years of experience as a Life Sciences and Healthcare lawyer, as a counsel and a litigator, Pascale advises major international pharmaceutical companies, medical device companies, biological and generic companies, biotech, research centers, cosmetic companies, and food manufacturers on major legal, contractual, judicial and regulatory issues, such as health product regulations, consumer protection, market access, compliance, anti-gift law, transparency law, data protection, contracts/agreements in the life sciences and healthcare sectors. In addition, Pascale also handles related constitutional, administrative, European, criminal and consumer law aspects. She is also specialized in issues including negotiations/litigation proceedings before national and EU regulatory authorities.

Jacques-Antoine Robert

Jacques-Antoine is a partner in the Paris office, he is a general commercial lawyer, acting mainly for major industrial groups - notably high tech and pharmaceutical companies - shareholders of such groups or investment funds. He represents his clients in regulatory matters, transactions and disputes involving commercial and/or liability issues. Jacques-Antoine works in contract law including termination of agreements, transfer of agreements, advertising and distribution networks. He has notably participated in recent major operations, concerning regulatory and competition law for a high tech manufacturer. He has been involved in major product liability cases and has recently won a highly publicized case before the French Supreme judicial court on behalf of a multinational industrial firm (September 2003).